Deloitte, the business advisory firm, has selected the NSPCC and Cancer Research UK as its national charity partners for 2008 and 2009, following a vote by more than 5,300 of its UK employees. Staff voted for one health and medical charity and one welfare charity, based on a shortlist of eight of each drawn up after nominations by Deloitte employees.

Announcing the result, Deloitte’s Director of Community Investment, Richard Stone said: “This is a fantastic response by our people and demonstrates just how important our charity partnerships are for the firm.

“We are looking forward to working with the NSPCC and Cancer Research UK which are two of the UK’s leading charities. We’re planning to raise more than £1m for them during the next two years, supporting their vital work, through fundraising and payroll giving, and there will also be opportunities for our people to get involved through volunteering and providing professional support.”

NSPCC Deputy Director of Fundraising, Tim Hunter said: “Without the support of partners like Deloitte and their staff we would not be able to continue our work with vulnerable children and young people who really need our help. Together with Cancer Research UK, the NSPCC is looking forward to the next two years working with Deloitte’s truly committed staff on a range of exciting fundraising initiatives.”

Paul Farthing, Corporate Partnerships Director at Cancer Research UK said; “Cancer Research UK is really delighted to have been chosen, along with the NSPCC, to be one of Deloitte’s charity partners for 2008/09.  We are excited about the opportunity of working with Deloitte’s passionate staff over the next two years to make this partnership a great success.  The money raised will help fund the vital research needed to beat cancer, and save more lives”

Richard Stone added: “Deloitte’s partnership with the British Heart Foundation and Leukaemia Research over the past two years has been an outstanding success and we’re going to build on that success going forward with our new charities.”

By way of recognition for the support that was given to the other short listed charities, Deloitte will be making a separate donation of £1,000 to each of the unsuccessful candidates in this year’s vote.

Ends

About the NSPCC
The NSPCC’s purpose is to end cruelty to children. Its vision is of a society where all children are loved, valued and able to fulfil their potential. We seek to achieve cultural, social and political change – influencing legislation, policy, practice, attitudes and behaviours for the benefit of children and young people. For more information visit www.nspcc.org.uk. 

About Cancer Research UK

• Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
• Cancer Research UK carries out world-class research to improve understanding of the disease and find out how to prevent, diagnose and treat different kinds of cancer.
• Cancer Research UK ensures that its findings are used to improve the lives of all cancer patients.
• Cancer Research UK helps people to understand cancer, the progress that is being made and the choices each person can make.
• Cancer Research UK works in partnership with others to achieve the greatest impact in the global fight against cancer.

For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7009 8820 or visit www.cancerresearchuk.org.uk.

About Deloitte
In this press release references to Deloitte are references to Deloitte & Touche LLP, which is among the country's leading professional services firms.  Deloitte & Touche LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu ("DTT"), a Swiss Verein whose member firms are separate and independent legal entities.  Neither DTT nor any of its member firms has any liability for each other's acts or omissions.  Services are provided by member firms or their subsidiaries and not by DTT.  Deloitte & Touche LLP is authorised and regulated by the Financial Services Authority.